MHMohamed A. Hasan

Mohamed A. Hasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamed A. Hasan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmed El-Olemy

    Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

    3 shared publications
  • Ahmed M. Abdel-Raoof

    Al-Azhar University

    2 shared publications
  • Ahmed W. Madkour

    Pharmaceutical Analytical Chemistry Dept., Faculty of Pharmacy, Al-Azhar University, Cairo 11751, Egypt

    2 shared publications
  • Khalid A.M. Attia

    Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, 11751, Cairo, Egypt

    2 shared publications
  • Ragab A Said

    Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, 11751 Nasr City, Cairo, Egypt

    2 shared publications
  • Abdalla M. El-Shanawany

    Pharmacist at Al-Azhar University, Cairo, Egypt

    1 shared publication

Latest Publications

  • Development of Stability‐Indicating Spectrofluorimetric Method for Favipiravir Determination Using 4‐Fluoro‐7‐Nitrobenzo‐2‐Oxa‐1,3‐Diazole Derivatization: Application to Quality Control and Therapeutic Drug Monitoring

    by Mohamed W. Nassar, Ahmed Serag, Mohamed A. Hasan, Mohamed Kamel

    A sensitive, accurate, and stability‐indicating spectrofluorimetric method was developed and validated for favipiravir determination in the presence of its acid‐induced degradation product. The method employs selective chemical derivatization with 4‐fluoro‐7‐nitrobenzo‐2‐oxa‐1,3‐diazole (NBD‐F) to overcome inherent analytical challenges associated with weak native fluorescence and spectral overlap between the parent compound and degradation products. Comprehensive characterization of the acid‐induced degradation product was achieved through infrared spectroscopy, 1 H NMR, and mass spectrometry, confirming amide hydrolysis to the corresponding carboxylic acid derivative. The derivatization mechanism exploits functional group differences, where favipiravir's primary amide undergoes nucleophilic substitution with NBD‐F forming a highly fluorescent adduct ( λ ex = 472 nm, λ em = 530 nm), while the degradation product remains nonreactive, providing inherent selectivity. Systematic optimization of derivatization conditions established optimal parameters: pH 8.0 borate buffer, 70°C for 25 min, and 1.5 mL of 0.2% NBD‐F. The method demonstrated excellent linearity over 0.01–0.25 μg/mL with remarkable sensitivity (LOD = 0.0028 μg/mL, LOQ = 0.0094 μg/mL), representing significant improvement over conventional HPLC‐UV methods. The method was successfully applied to pharmaceutical formulation analysis and human plasma samples. This stability‐indicating approach provides a valuable analytical tool for favipiravir quality control and therapeutic drug monitoring.

  • Eco‐Friendly Simultaneous Quantification of Domperidone and Safinamide by Spectral Resolution using deconvoluted Synchronous Fluorescence: Application to Spiked Human Plasma

    by Ebraam B. Kamel, Omar M El‐Abassy, Mohamed A. Hasan, Israa M. Nour, Mohamed Badrawy

    A novel, eco‐friendly deconvoluted synchronous spectrofluorimetric method has been developed and validated for the simultaneous determination of domperidone (DOM) and safinamide (SAF), a potential combination used to address Parkinson's disease–associated gastrointestinal dysfunction. Their combined administration necessitates a reliable analytical method for therapeutic monitoring and formulation quality control. Traditional spectrofluorimetric techniques fail to resolve the significant spectral overlap between these two compounds. In this study, a deconvoluted synchronous spectrofluorimetric method, using Fourier self‐deconvolution at Δλ = 30 nm, successfully resolved the overlapping fluorescence spectra without any need for physical separation. It showed excellent linearity (DOM: 10–1500 ng/mL, SAF: 50–2000 ng/mL), with low LOD (2.75 ng/mL for DOM and 11.77 ng/mL for SAF), high recovery rates in both pharmaceutical forms and spiked human plasma (above 90%), and outstanding selectivity and robustness. Sustainability of the current method was assessed using spider chart measure, green solvent selection tool, Analytical GREEnness Metric, Modified Green Analytical Procedure index, and Blue Applicability Grade Index. The proposed technique represents a simple, sensitive, and sustainable tool for routine analysis of this therapeutically significant drug pair.


  • Open Access

    Green first derivative synchronous spectrofluorimetric determination of lacidipine and its acid degradation product in plasma and mixtures

    by Khalid A.M. Attia, Mohamed A. Hasan, Abdalla M. El-Shanawany

    One of the main objectives of this study is to find an analysis method that has a low environmental and health impact and contributes to achieving sustainability. A simple and sensitive method was established for determination of lacidipine in pure active pharmaceutical ingredient, pharmaceutical formulation and spiked human plasma in presence of its acid induced degradation product. The native emission was measured at 430 nm after the excitation at 281 nm. A 0.5% Tween-80 solution was used to enhance fluorescence intensity. Peak amplitude of the first derivative synchronous was measured at 409 nm by using constant wavelength difference (Δλ = λem - λex = costant) which equal 160 nm. The regression plot of the proposed first derivative synchronous spectrofluorimetric method was found to be linear over the range of 50–300 ng/mL with a determination coefficient equals 0.9997, limit of detection (LOD) was 14.51 ng/mL but limit of quantification (LOQ) was 43.97 ng/mL.

  • An ultrasensitive green synchronous factorized spectrofluorimetric approach for the simultaneous determination of Favipiravir and Molnupiravir: Application to pharmaceutical, environmental, and biological matrices

    by Menna S. ElSherbiny, Sherif M. Eid, Khadiga M. Kelani, Maha F. Abdel Ghany, Ahmed El‐Olemy, Mohamed A. Hasan, Mahmoud M. Abbas

    During the pandemic, Favipiravir (FVP) and Molnupiravir (MPV) have been widely used for COVID‐19 treatment, leading to their presence in the environment. A green synchronous spectrofluorimetric method was developed to simultaneously detect them in environmental water, human plasma, and binary mixtures. Maximum fluorescence intensity was achieved at pH 8, with MPV exhibiting two peaks at 300 and 430 nm, and FVP showing one peak at 430 nm. A fluorescence subtraction method effectively removed interference, enabling direct determination of MPV at 300 nm and FVP at 430 nm. The method showed linearity within 2–13 ng/mL for FVP and 50–600 ng/mL for MPV, with recoveries of 100.35% and 100.12%, respectively. Limits of detection and quantification were 0.19 and 0.57 ng/mL for FVP and 10.52 and 31.88 ng/mL for MPV. Validation according to ICH and FDA guidelines yielded acceptable results. The method demonstrated good recoveries of FVP and MPV in pharmaceuticals, tap water and Nile water (99.62% ± 0.96% and 99.69% ± 0.64%) as per ICH guidelines and spiked human plasma (94.87% ± 2.111% and 94.79% ± 1.605%) following FDA guidelines, respectively. Its environmental friendliness was assessed using Green Analytical Procedure Index (GAPI) and the Analytical Greenness Metric (AGREE) tools.


  • Open Access

    Second derivative synchronous fluorescence determination of avanafil in the presence of its acid-induced degradation product aided by powerful Lean Six Sigma tools augmented with D-optimal design

    by Khalid A. M. Attia, Ahmad A. Mohamad, Mohamed S. Emara, Ahmed M. Abdel-Raoof, Mohamed A. Hasan, Ahmed W. Madkour, Ebrahim A. El-Desouky

    In this work, the quantitative determination of an erectile dysfunctional drug avanafil in the presence of its acid-induced degradation product was achieved via the application of a pre-optimized novel spectrofluorimetric method. The fluorescence emission wavelength was recorded at 370 and 407 nm, after being excited at 268 and 271 nm for avanafil and its acid-induced degradation product, respectively. Direct determination of avanafil based on its native fluorescence is restricted because the emission spectra of both components are heavily overlapped. Therefore, to overcome this constraint, a novel second derivative synchronous fluorescence method was evolved to eliminate this overlapping. The ideal determination wavelength was found to be 377 nm. Augmentation of lean six sigma (LSS) with response surface methodology (RSM) play a significant role in the development of robust specifications to ensure quality at the six sigma level with a high level of statistical confidence and targeted performance. All of the experimental conditions were optimized using D-optimal design as a RSM to select the optimal parameters. In addition, this work includes a graphical representation of the relationships between various variables that can greatly affect the results and the intensity of the synchronous fluorescence.


  • Validated Liquid Chromatography–Tandem Mass Spectroscopic Method for Simultaneous Determination of Certain Drugs Used in Cataract Surgery in Rabbit Aqueous Humor

    by Mohammed W Nassar, Khalid A Attia, Ahmed A Mohamed, Ragab A Said, Ahmed El-Olemy, Mohamed A Hasan

    A sensitive, selective, accurate and precise ultra-high performance liquid chromatography–Tandem mass spectrometry (MS/MS) method was developed and validated for the simultaneous determination of drugs used as eye drops in cataract surgery in aqueous humor. Cataract surgery requires a powerful mydriatic eye drops combination such as cyclopentolate hydrochloride and phenylephrine hydrochloride to dilate the pupil and facilitate eye lens replacement and also requires strong fluoroquinolone antibiotic such as lomefloxacin hydrochloride. The method was performed with positive ion electrospray ionization and the analytes were quantified and monitored on a triple quadrupole mass spectrometer using multiple reaction monitoring scanning mode. Liquid–liquid extraction was used for the purification and preconcentration of analytes from rabbit aqueous humor matrix. Chromatographic elution was performed using an Phenomenex Luna® C18 (150 mm × 2.1 mm, 1.6 μm) column and moxifloxacin hydrochloride as internal standard with a mobile phase consisting of methanol:water:formic acid (70:29:1, by volume) at flow rate of 0.2 mL/min. Satisfactory results regarding linearity, recovery, stability, accuracy and precision of the analytes were obtained. Full validation of the procedure was performed according to the US Food and Drug Administration guidance for industry: bioanalytical method validation and European Medicines Agency (EMA) guideline on bioanalytical method validation.


  • Simultaneous determination of citalopram and tadalafil by the second derivative synchronous fluorescence method in biological fluids; application of Box–Behnken optimization design

    by Ahmed M. Abdel‐Raoof, Mohamed A. Hasan, Ahmed W. Madkour, Ashraf Abdel‐Fattah, Maya S. Eissa

    This is the first study focusing solely on that determination of tadalafil in the presence of citalopram as an antidepressant drug. The determination in biological fluids of a co‐administered antidepressant drug and a sexual stimulation drug is a very critical and important step for psychotic and ischaemic heart disease patients, especially in cases of emergency and this requires therapeutic drug monitoring. A sensitive, efficient and rapid assay was selected satisfactorily and applied for simultaneous determination of citalopram and tadalafil either in their pure forms, in tablet dosage forms or in spiked human plasma. There was a large overlap for both drugs, forming the broad band found in conventional fluorescence spectra and their related synchronous fluorescence intensity. Therefore, the development of a highly sensitive second derivative synchronous fluorescence method was demonstrated that removed this overlap. The proposed method depended on measuring the amplitudes of the second derivative of synchronous fluorescence intensity at suitable wavelengths of 301 nm and 367 nm for citalopram and tadalafil at Δλ = 60 nm, respectively. Box–Behnken design as a response surface methodology was used to fit models and create an optimization process encompassing a set of factors and resulting in an optimum response value specifically designed for this method. Under optimum conditions, the linear dynamic ranges for citalopram and tadalafil estimation were 20–900 and 5–400 ng ml−1 with detection limits of 5.40 and 1.43 ng ml−1, respectively.